Biochemical Markers and Bone Mineral Density in Patients with Hip Fractures in Men

References

• Riggs B. L., Melton L. J. Medical progress series: Involutional osteoporosis. N Engl J Med 1986; 314: 1676–1686
   PubMed Web of Science ®Google Scholar
• Seeman E., Melton LJ, III, O'Fallon W. M., Riggs B. L. Risk factors for spinal osteoporosis in men. Am J Med 1983; 75: 977–983
   PubMed Web of Science ®Google Scholar
• Garnero P., Hausherr E., Chapuy M-C, Marcelli C., Grandjean H., Muller C., Cormier C., Breart G., Meunier P. J., Delmas P. D. Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study. J Bone Miner Res 1996; 11: 1531–1538
   PubMed Web of Science ®Google Scholar
• Melton L J, III, Khoslar S., Atkinson E. J., O'Fallon W. M., Riggs B. L. Relationship of bone turnover to bone density and fracture. J Bone Miner Res 1997; 12: 1083–1091
   PubMed Web of Science ®Google Scholar
• Nydegger V., Rizzoli R., Rapin C. H., Vasey H., Bonjour J. PH. Epidemiology of fractures of the proximal femur in Geneva: Incidence, clinical and social aspect. Osteoporosis Int 1991; 2: 42–47
   PubMed Web of Science ®Google Scholar
• Fisher E. S., Baron J. A., Malenka P. J., Barrett J. A., Kniffin W. D., Whaley F. S., Bubolz T. A. Hip fracture incidence and mortality in New England. Epidemiology 1991; 2: 116–122
   PubMedGoogle Scholar
• Colvard D. S., Eriksen E. F., Keeting P. E., Wilson E. M., Lubahn D. B., French F. S., Riggs B. L., Spelsberg TC. Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci 1989; 86: 854–857
   PubMed Web of Science ®Google Scholar
• Finkelstein J. S., Klibanski A., Neer R. M., Greenspan S. L., Rosenthal D. I., Crowley W. F. Osteoporosis in men with hypogonadotropic hypogonadism. Ann Intern Med 1987; 106: 354–361
   PubMed Web of Science ®Google Scholar
• Jackson J. A., Kleerekoper M., Parfit A. M. Symptomatic osteoporosis in a man with hyperprolactinemic hypogonadism. Ann Int Med 1986; 105: 543–545
   PubMed Web of Science ®Google Scholar
• Finkelstein J. S., Klibanski A., Neer R. M., Doppelt S. H., Rosenthal D. I., Segre G. V., Crowley W. F. Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1989; 69: 776–783
   PubMed Web of Science ®Google Scholar
• Rigotti N. A., Neer R. M., Jameson L. Osteopenia and bone fractures in a man with anorexia nervosa and hypogonadism. JAMA 1986; 256: 385–388
   PubMed Web of Science ®Google Scholar
• Ohishi T., Koide Y., Takahashi M., Oikawa M., Kushida K. A case of femoral neck fracture in a patient with severe testosterone deficiency. J Bone Miner Metab 1999; 17: 51–54
   PubMed Web of Science ®Google Scholar
• Jackson J. A., Riggs M. W., Spiekerman A. M. Testosterone deficiency as a risk factor for hip fractures in men: a case-control study. Am J Med Sci 1992; 304(1)4–8
   PubMed Web of Science ®Google Scholar
• Stanley H. L., Schmitt B. P., Poses R. M., Deiss W. P. Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men?. JAGS 1991; 39: 766–771
   PubMed Web of Science ®Google Scholar
• Greenspan S. L., Oppenheim D. S., Klibanski A. Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. Ann Intern Med 1989; 110: 526–531
   PubMed Web of Science ®Google Scholar
• Tenover JS. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 1992; 75: 1092–1098
   PubMed Web of Science ®Google Scholar
• Anderson F. H., Francis R. M., Peaston R. T., Wastell H. J. Androgen supplementation in eugonadal men with osteoporosis: effects of six months treatment on markers of bone formation and resorption. J Bone Miner Res 1997; 12: 472–478
   PubMed Web of Science ®Google Scholar
• Slemenda C. W., Longcope C., Zhou L., Hui S. L., Peacock M., Johnston C. C. Sex steroids and bone mass in older men - Positive associations with serum estrogens and negative associations with androgen. J Clin Invest 1997; 100: 1755–1759
   PubMed Web of Science ®Google Scholar
• Rosenquist C., Qvist P., Bjarnason N., Cristiansen C. Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies. Clin Chem 1995; 10: 1439–1445
   Google Scholar
• Takahashi M., Kushida Y., Hoshino H., Ohishi T., Inoue T. Investigation of the performance of ELI SA for N-terminal midfragment of osteocalcin. J Bone Miner Metab 1997; 15: 132–137
   Google Scholar
• Pratt D. A., Daniloff Y., Duncan A., Robins S. P. Automated analysis of the pyridinium crosslinks of collagen in tissue and urine using solid-phase extraction and reversed-phase high-performance liquid chromatography. Anal Biochem 1992; 207: 163–175
   PubMed Web of Science ®Google Scholar
• Bonde M., Qvist P., Fledelius C., Riis B. J., Christiansen C. Immunoassay for quantifying type I collagen degradation products y in urine evaluated. Clin Chem 1994; 40: 2022–2025
   PubMed Web of Science ®Google Scholar
• Bonde M., Qvist P., Fledelius Q, Riis B. J., Christiansen C. Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): Follow-up on hormone replacement therapy and osteoporosis risk assessment. J Clin Endocrinol Metab 1995; 80: 864–868
   PubMed Web of Science ®Google Scholar
• Bonde M., Garnero P., Fledelius C., Qvist P., Delmas P. D., Christiansen C. Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen. J Bone Miner Res 1997; 12: 1028–1034
   PubMed Web of Science ®Google Scholar
• Orimo H., Sugioka Y., Hukunaga H., Muto Y., Hotokebuchi T., Gorai I., Nakamura T., Kushida K., Tanaka H., Ikai T., Oh-hashi Y. Diagnostic criteria of primary osteoporosis. J Bone Miner Metab 1996; 4: 643–652
   Google Scholar
• Boonen S., Vanderschueren D., Cheng X. G., Verbeke G., Dequeker J., Geusens P., Broos P., Bouillon R. Age-related (type II) femoral neck osteoporosis in men: Biochemical evidence for both hypovitaminosis D-and androgen deficiency-induced bone resorption. J Bone Miner Res 1997; 12: 2119–2126
   PubMed Web of Science ®Google Scholar
• Takahashi M., Kushida K., Hoshino H., Ohishi T., Inoue T. Evaluation of bone turnover in postmenopause, vertebral fracture, and hip fracture using biochemical markers for bone formation and resorption. J Endocrinol Invest 1997; 20: 112–117
   PubMed Web of Science ®Google Scholar
• Ohishi T., Kushida K., Takahashi M., Hoshino H., Tsuchikawa T., Naitoh K., Inoue T. Changes of biochemical markers during fracture healing. Arch Orthop Trauma Surg 1998; 118: 126–130
   PubMed Web of Science ®Google Scholar